Vimarsana
Biggest News Aggregation in the World

Page 5 - Safety Update News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Safety Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Safety Update Today - Breaking & Trending Today

Aggravated Harassment Charges For Threat To Hudson Valley School - Vimarsana News

Aggravated Harassment Charges For Threat To Hudson Valley School

Another threat was made within the Wappingers Central School District, this time leading to Aggravated Harassment charges.

Source: wrrv.com
Additional Positive Interim Data from Phase I/II/III CAMPSIITE™ Trial of REGENXBIO's RGX-121 for the Treatment of MPS II (Hunter Syndrome) Presented at 19th Annual WORLDSymposiumTM - Vimarsana News

Additional Positive Interim Data from Phase I/II/III CAMPSIITE™ Trial of REGENXBIO's RGX-121 for the Treatment of MPS II (Hunter Syndrome) Presented at 19th Annual WORLDSymposiumTM

RGX-121, a potential one-time gene therapy for the treatment of MPS II, continues to be well-tolerated with no drug-related SAEs across three dose levels...

REGENXBIO Presents Positive Interim Data from and the Expansion of Phase II ALTITUDE® Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery - Vimarsana News

REGENXBIO Presents Positive Interim Data from and the Expansion of Phase II ALTITUDE® Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery

RGX-314 continues to be well tolerated in 50 patients from Cohorts 1-3 with no drug-related serious adverse events Patients treated with RGX-314 in Cohorts 1-3...

Police, ADA plan updates on agenda at Bennington Select Board meeting - Vimarsana News

Police, ADA plan updates on agenda at Bennington Select Board meeting

BENNINGTON — The Bennington Select Board will meet on Monday at 6 p.m. at the Bennington Fire Facility. The full agenda and packet can be found in paper form at

REGENXBIO Announces Additional Positive Interim Data from Trials of RGX-314 for the Treatment of Wet AMD - Vimarsana News

REGENXBIO Announces Additional Positive Interim Data from Trials of RGX-314 for the Treatment of Wet AMD

Company announced positive interim data from and the expansion of Phase II AAVIATE® trial of RGX-314 for the treatment of wet AMD using suprachoroidal delivery...